Company Presentations

We are opening limited slots on November 17th for “Company Presentations”, to provide equal opportunities to all interested growth companies, startups, and participants to promote their business to potential investors and decision makers.

This is your opportunity to promote your company in front of global investors.

The DxPx Conference at a Glance:
ONE DAY ON-SITE – EIGHT DAYS DIGITAL PARTNERING.

One Day On-Site: November 16th, 2021
8 Days Digital Partnering: November 12th – 20th, 2021

Knowledge Insights

Our Knowledge Partners McKinsey & Company, Brown Gibbons Lang & Co., McDermott Will & Emery and Silversky LifeSciences share their views on market trends.

ONE-TO-ONE MEETINGS

To maximize the networking we will have 20 min slots for one-to-one meetings on the conference day and 30 min virtual meetings on four days prior and after.

EXHIBITION

Promote your company to executives and investors and showcase your products at your individual booth.

42PLUS1 PITCH AWARD

Witness the next generation first hand and hear the pitches of our 8 finalists.

PANEL DISCUSSIONS & FIRESIDE CHATS

Witness the next generation first hand and hear the pitches of our 8 finalists.

Company presentations

Present your company to investors, C-level executives & entrepreneurs from 30+ countries,
for 20 minutes from ANYWHERE.

RECEPTION

Get together with new acquaintances and find out who won the 42PLUS1 Pitch Award.

Meet Investors from Anywhere in the world.

This is your opportunity to promote your company with a pre-recorded video pitch in front of investors. 

The company presentations are going to be 100% virtual so registered participants will be submitting pre-recorded video material showcasing their business, lasting up to 20 minutes!  

Anyone can apply from anywhere in the world! – as long as you’re investment-ready!

Guidelines on the company presentation video material will be sent separately to those who are interested to participate in the “Company Presentations” segment. Our event’s team is here to support you with detailed instructions so you can develop a seamless pre-recorded video that presents you in the best light.

 What’s in it for you?

  • Present your company to investors, C-level executives & entrepreneurs from 30+ countries. Pre-recorded company presentations shall be posted on the DxPx website for  months to gain longer visibility.

  • Pitch your business venture for potential financing, licensing, and M&A partnerships.

  • Promote your company and gain incredible attention from renowned decision makers, and executives from the industry.

Grab this chance to showcase your company’s vision, goal, and market potential by promoting your business and pitching in front of investors from all over the world.

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience